SeQuent Scientific Announces Q1 FY18 Financial Results

SeQuent Scientific Announces Q1 FY18 Financial Results

Strong Revenue Momentum

Commenting on the Company’s performance, Manish Gupta, Managing Director said “We have made a strong start to the year with a revenue growth of 54% aided by steady growth across all geographies. We are particularly happy with the strong growth in EBITDA, which reflects the quality of business we are pursuing and the operational discipline. All our inorganic strategies have been integrated well and continues to scale up. The recent USFDA approval of our facility in Vizag will accelerate the growth momentum in the coming quarters”.

Print
Posted: Aug 3, 2017,
Comments: 0
Tags:

Documents to download

Name:
Email:
Subject:
Message:
x

Archives

2016-2017



2015-2016



2014-2015



2013-2014



2012-2013